New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
09:27 EDTGE, LIFE, TMO, RHHBYLife Technologies potential buyers could have better options, says Piper Jaffray
After Life Technologies (LIFE) said it hired two investment banks to aid in its annual strategic review, Piper Jaffray said it believes a takeover or leveraged buyout is potentially in the works. Piper said it sees several potential acquirers for Life, listing Roche (RHHBY), Thermo Fisher (TMO) and General Electric (GE) as possibly making strategic sense. However, Piper says the slower growing Research Consumables business makes up 43% of Life's revenue. As such, it believes an acquirer interested in the faster growing next-gen sequencing business has better options. Piper has a Neutral rating on shares of Life Technologies.
News For LIFE;RHHBY;TMO;GE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
December 16, 2014
15:07 EDTGEGeneral Electric sees FY15 Industrial EPS $1.10-$1.20
Subscribe for More Information
15:02 EDTGEGeneral Electric sees returning $10B-$30B to investors in FY15
Subscribe for More Information
14:57 EDTGEGeneral Electric says Alstom synergy opportunities better than expected
Subscribe for More Information
14:54 EDTGEGE repeats view for FY14 revenue flat to up 5%, consensus $148.92B
Subscribe for More Information
09:22 EDTGEGeneral Electric must answer on oil and gas focus after price slide, WSJ says
Subscribe for More Information
08:47 EDTRHHBYHemispherx Ampligen provides anti-tumor activity
Subscribe for More Information
08:03 EDTGEGeneral Electric to acquire Oceaneering's Electric Actuator product line
Subscribe for More Information
05:56 EDTGEBoeing selects GE Aviation for ELMS on 777X
Subscribe for More Information
05:46 EDTRHHBYRoche launches PCR molecular diagnostic system for point of care environment
Subscribe for More Information
December 15, 2014
12:01 EDTGEBioTime unit, GE Healthcare sign set of license agreements, terms not disclosed
BioTime (BTX) announced that its subsidiary ES Cell International Pte. Ltd. and GE Healthcare (GE) have signed a set of license agreements through which GEHC received rights to ESIís stem cell patents and ESI received rights to stem cell patents controlled by GEHC, in both cases for the development of cellular assays and models derived from stem cells for use in drug discovery and toxicity screening. In addition, the agreements give GEHC the right to grant sub-licenses to the ESI patent portfolio and, in certain circumstances, ESI may further sublicense its rights for the purpose of marketing stem cell-derived products. Financial terms were not disclosed.
11:17 EDTGEGE Aviation selected by Boeing for 777x common core avionics systems
Subscribe for More Information
08:15 EDTGEGeneral Electric to host investor meeting
Subscribe for More Information
08:08 EDTGEGeneral Electric enters into IP licensing agreement with WordLogic
Subscribe for More Information
05:24 EDTRHHBYExelixis announces Genentech files NDA for cobimetinib, vemurafenib combination
Exelixis (EXEL) announced its collaborator Genentech, a member of the Roche Group (RHHBY), has completed the filing of its New Drug Application, or NDA, with the FDA for cobimetinib, a specific MEK inhibitor discovered by Exelixis, in combination with vemurafenib for previously untreated patients with unresectable locally advanced or metastatic melanoma harboring a BRAF V600 mutation. Cobimetinib has received Fast Track designation by the FDA. Roche submitted a Marketing Authorization Application for the combination to the European Medicines Agency in September of this year. The NDA is based on data from the coBRIM trial, a phase 3 pivotal trial conducted by Genentech in 495 patients with BRAF V600 mutation-positive unresectable locally advanced or metastatic melanoma.
December 12, 2014
11:57 EDTGEGeneral Electric increases dividend 5% to 23c from 22c
Subscribe for More Information
11:57 EDTGEGeneral Electric increases dividend 5% to 23c from 22c
Subscribe for More Information
05:52 EDTRHHBYRoche announces retirement of Genentech research head
Subscribe for More Information
December 10, 2014
08:04 EDTGEGE Energy Financial Services, Pacifico to build second joint solar project
Subscribe for More Information
December 9, 2014
12:22 EDTRHHBYPiper Jaffray biopharm analyst holds an analyst/industry conference call
Senior Research Analyst Schimmer, along with Biopharmaceuticals Analyst Breazzano, discuss gene therapy for hemophilia on an Analyst/Industry conference call to be held on December 11 at 10 am.
07:44 EDTRHHBYAmerican Association for Cancer Research to hold a symposium
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use